Concepedia

Andrew W. Chung

AW

3

Publications

184

Citations

3

H-Index

2012

Active since

Affiliations

University of California, Los Angeles(Current)

Houston Methodist

Andrew W. Chung is an author at University of California, Los Angeles.

Publications per year

2012–2022

3

Publications

3

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer

Andrew W. Chung, Kartik Anand, Ann C. Anselme et al. · Science Translational Medicine · 2021 · 102 citations

Galectin-3 Regulates the Innate Immune Response of Human Monocytes

Andrew W. Chung, Peter A. Sieling, Mirjam Schenk et al. · The Journal of Infectious Diseases · 2012 · 52 citations · Full text

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6

Andrew W. Chung, Anthony J. Kozielski, Wei Qian et al. · npj Breast Cancer · 2022 · 30 citations · Full text

Rows per page

1–3 of 3